These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 39244288)
1. Treatment De-escalation in Oropharyngeal Carcinoma and the Role of Robotic Surgery. Ceremsak J; Ye W; Hicks M; Mannion K Surg Oncol Clin N Am; 2024 Oct; 33(4):697-709. PubMed ID: 39244288 [TBL] [Abstract][Full Text] [Related]
2. The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma. Sload R; Silver N; Jawad BA; Gross ND Curr Oncol Rep; 2016 Sep; 18(9):53. PubMed ID: 27469262 [TBL] [Abstract][Full Text] [Related]
3. Transoral robotic surgery for oropharyngeal squamous cell carcinoma in the era of human papillomavirus. Mahmoud O; Sung K; Civantos FJ; Thomas GR; Samuels MA Head Neck; 2018 Apr; 40(4):710-721. PubMed ID: 29244238 [TBL] [Abstract][Full Text] [Related]
4. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma. Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641 [TBL] [Abstract][Full Text] [Related]
5. A Descriptive Study of Quality of Life Following Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma. Diaconescu A; Silver JA; Subramaniam T; Sewitch MJ; Mascarella MA; Ramirez-Garcia Luna J; Golabi N; Richardson K; Bouganim N; Forghani R; Marcin Mlynarek A; Hier MP; Sadeghi N J Otolaryngol Head Neck Surg; 2024; 53():19160216241248670. PubMed ID: 38888957 [TBL] [Abstract][Full Text] [Related]
6. Current Indications for Transoral Robotic Surgery in Oropharyngeal Cancer. Parhar HS; Yver CM; Brody RM Otolaryngol Clin North Am; 2020 Dec; 53(6):949-964. PubMed ID: 32912662 [TBL] [Abstract][Full Text] [Related]
7. Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study. Kornfeld B; Taha A; Kyang L; Sim HW; Dewhurst S; McCloy R; Chin V; Earls P; Parker A; Leavers B; Forstner D; Floros P; Crawford J; Gallagher R J Robot Surg; 2024 May; 18(1):226. PubMed ID: 38806847 [TBL] [Abstract][Full Text] [Related]
8. Transoral Robotic Surgery and De-escalation of Cancer Treatment. Wahle B; Zevallos J Otolaryngol Clin North Am; 2020 Dec; 53(6):981-994. PubMed ID: 32917423 [TBL] [Abstract][Full Text] [Related]
9. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status. Ford SE; Brandwein-Gensler M; Carroll WR; Rosenthal EL; Magnuson JS Otolaryngol Head Neck Surg; 2014 Oct; 151(4):606-11. PubMed ID: 25049265 [TBL] [Abstract][Full Text] [Related]
10. The Role of Surgery in the Management of Recurrent Oropharyngeal Cancer. Gross ND; Hanna EY Recent Results Cancer Res; 2017; 206():197-205. PubMed ID: 27699540 [TBL] [Abstract][Full Text] [Related]
11. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery. Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634 [TBL] [Abstract][Full Text] [Related]
12. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020. Meldgaard Justesen M; Kronberg Jakobsen K; Fenger Carlander AL; Hjordt Holm Larsen M; Wessel I; Kiss K; Friborg J; Ibrahim Channir H; Rubek N; Grønhøj C; von Buchwald C Oral Oncol; 2024 May; 152():106783. PubMed ID: 38569317 [TBL] [Abstract][Full Text] [Related]
13. Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery. Roden DF; Hobelmann K; Vimawala S; Richa T; Fundakowski CE; Goldman R; Luginbuhl A; Curry JM; Cognetti DM Cancer; 2020 Jan; 126(9):1873-1887. PubMed ID: 32032441 [TBL] [Abstract][Full Text] [Related]
14. Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer. Zebolsky AL; George E; Gulati A; Wai KC; Carpenter P; Van Zante A; Ha PK; Heaton CM; Ryan WR JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1080-1088. PubMed ID: 34673904 [TBL] [Abstract][Full Text] [Related]
15. Specimen-Based Resection Margins and Local Control during Transoral Robotic Surgery for Oropharyngeal HPV-Mediated Squamous Cell Carcinoma. Magliocca KR; Kaka AS; Barrow EM; Studer MB; Griffith CC; Ernst J; Meade T; Balicki A; Boyce BJ; Schmitt NC; Bur AM; Schmitt AC; Jackson R; Steuer CE; Beitler JJ; Patel MR ORL J Otorhinolaryngol Relat Spec; 2023; 85(2):80-87. PubMed ID: 36538901 [TBL] [Abstract][Full Text] [Related]
16. Open Versus Robotic Surgery for Oropharyngeal Cancer. Jefferson GD; Frey H Otolaryngol Clin North Am; 2020 Dec; 53(6):995-1003. PubMed ID: 32854946 [TBL] [Abstract][Full Text] [Related]
17. [The clinical value of oral robotic surgery in the treatment of oropharyngeal squamous cell carcinoma]. Zhang X; Yang ZY; Yang AK; Zhang Q; Li QL; Chen SW; Chen JT; Song M Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):570-576. PubMed ID: 35754232 [No Abstract] [Full Text] [Related]
18. Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Improving Function While Maintaining Oncologic Outcome. Scholfield DW; Gujral DM; Awad Z Otolaryngol Head Neck Surg; 2020 Mar; 162(3):267-268. PubMed ID: 31961759 [TBL] [Abstract][Full Text] [Related]
19. Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma. Chillakuru Y; Benito DA; Strum D; Mehta V; Saini P; Shim T; Darwish C; Joshi AS; Thakkar P; Goodman JF Head Neck; 2021 Jul; 43(7):2259-2273. PubMed ID: 33899949 [TBL] [Abstract][Full Text] [Related]
20. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS). Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]